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ABSTRACT
The prime mechanism by which p53 acts as a tumor
suppressor is as a transcription factor regulating
the expression of diverse downstream genes. The
DNA-binding domain of p53 (p53DBD) interacts
with defined DNA sites and is the main target for
mutations in human primary tumors. Here, we
show that the CWWG motif, found in the center of
each consensus p53 half-site, is a key player in p53/
DNA interactions. Gel-mobility-shift assays provide
a unique opportunity to directly observe the various
oligomeric complexes formed between p53DBD and
its target sites. We demonstrate that p53DBD binds
to p53 consensus sites containing CATG with rela-
tively low cooperativity, as both dimers and tetra-
mers, and with even lower cooperativity to such
sites containing spacer sequences. p53DBD binds
to sites containing CAAG and CTAG with measur-
able affinity only when imbedded in two contiguous
p53 half-sites and only as tetramers (with very high
cooperativity). There are three orders-of-magnitude
difference in the cooperativity of interaction
between sites differing in their non-contacted step,
and further two orders-of-magnitude difference as a
function of spacer sequences. By experimentally
measuring the global structural properties of these
sites, by cyclization kinetics of DNA minicircles, we
correlate these differences with the torsional flexi-
bility of the binding sites.
INTRODUCTION
The tumor suppressor protein p53 is a transcription factor
(TF) that in response to various types of cellular stress
regulates the expression of a variety of genes involved in
cell-cycle control, apoptosis, DNA repair and cell
differentiation (1–3), by binding sequence-speciﬁcally to
deﬁned DNA targets (4,5). Abrogation of p53 sequence-
dependent binding is implicated in  50% of all known
cancers (1,2). Recently, p53 was shown to have additional
roles in senescence, development and the immune system,
unrelated to cancer surveillance (6,7). The complexity of
p53 functions is mirrored in the complexity of its structure
and binding mechanism. p53 molecules consist of four
major functional domains (8). The N-terminus contains
a transactivation domain (TA); the core domain (CD)
contains the sequence-speciﬁc DNA-binding domain
(DBD); and the C-terminal domain includes a
tetramerization domain and a regulatory domain that
contain a separate sequence non-speciﬁc DNA-binding
activity (9). The core domain of p53 contains 95% of
the missense mutations identiﬁed in human tumors (10).
This highlights the importance of sequence-speciﬁc p53/
DNA interactions for p53 functions. The consensus
binding site deﬁned in vitro consists of two decameric
sequences, or half-sites, with the general form
RRRCWWGYYY (R=A,G;W=A,T;Y=C,T), sepa-
rated by 0–13bp (4). However, in vivo deﬁned binding
sites contain fewer spacer sequences (5,11).
We have recently shown that changes in both direct and
indirect readout of p53 DNA-binding sites (or response
elements, REs) play a central role in modulating the
DNA binding afﬁnity of p53DBD (12). In the crystal
structure determination of functional complexes of
p53DBD and three different DNA sequences, the
protein–DNA interface varies as a function of the DNA
base sequence (12). DNA-binding measurements show a
correlation between binding afﬁnities of the complexes
and the protein–DNA interface geometries, and that the
complexes varies in both direct-readout effects (changes in
protein–DNA contacts) and indirect-readout effects
(changes in DNA structure). The crystal structures of
p53DBD/DNA complexes (12,13) showed that the
middle WW dinucleotide (also called base-pair step or
doublet) in each half-site is not directly contacted in the
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highly conserved in natural p53 REs, with a marked pref-
erence for A–T and A–A, but not T–A base–pair steps
(14–16).
The level of DNA binding (17) and transcriptional ac-
tivation (14,18) vary signiﬁcantly among p53-regulated
genes, due to variations within the individual response
elements, their internal arrangement, number of decameric
repeats and location with respect to the start site (14,18).
Moreover, alteration in the non-contacted WW step
causes signiﬁcant changes in transactivation activity,
with A-T containing sequences being those with signiﬁ-
cantly higher activity (18,19). p53 was recently shown to
be functional also from sequences that have only one ca-
nonical half-site (20). Transactivation from these sites was
shown to be sequence-dependent and to operate through
the binding of p53 tetramers (20).
It is well established that the functional unit of p53
binding to DNA is a tetramer and that the binding of
p53 to its speciﬁc REs is highly cooperative (21–24).
p53DBD is monomeric in solution, whereas constructs
containing the tetramerization domain are mostly
dimeric in solution. Thus, tetramerization is mediated by
speciﬁc binding of p53 to its REs (24). The ability to
dimerize is encoded within p53DBD (12,25–28) and is
located in the H1 helix, the Zn cluster, and in regions of
the L2 and L3 loops from each CD. This intradimer
protein–protein interface, or symmetrical interface (12),
is stabilized by various salt bridges, hydrophobic inter-
actions and water-mediated polar interactions (12). The
other protein–protein interface observed in p53 tetramers
is the translational interface that forms between dimers
(12). We show here that p53 binding cooperativity is
encoded in the DNA sequence of p53 binding sites, and
that it spans ﬁve orders of magnitude as a function of
DNA sequence. The key to the differential changes in co-
operative binding is the torsional ﬂexibility of the central
CWWG motif of p53 binding sites, as determined from
cyclization kinetics experiments.
MATERIALS AND METHODS
Protein and DNA
Human p53 core domain (residues 94–293, referred to as
p53DBD) and a p53 construct containing the N-terminus
as well (p53TD, amino acids 1–290) were a kind gift from
Zippora Shakked (Weizmann Institute of Science). The
cloning, transformation, overexpression and puriﬁcation
are as described by Kitayner et al. (12). Protein concen-
tration was determined spectroscopically, using an
estimated extinction coefﬁcient of 17420 and
33920M
 1cm
 1, as calculated by the ProtParam tool of
the ExPASy server (29) for the p53DBD and p53TD con-
structs, respectively. Prior to the binding studies, the
fraction of p53DBD molecules active for DNA binding
was determined as described previously (30). All DNA
sequences for the electrophoretic mobility shift assay
(EMSA, shown in Table 1) were synthesized by Sigma
Genosys (Israel) and puriﬁed by a reverse-phase cartridge.
The sequences for the EMSA experiments were designed
as intramolecular hairpin constructs, with between 23 and
27bp in the stem, and with ﬁve cytosines in the loop as
previously described (12,30). Con3 sequence was also
synthesized as an intramolecular dumbbell construct
(Table 1), with two hairpin loops each containing ﬁve
cytosines (31). The DNA test sequences for cyclization
experiments [bottom polymerase chain reaction (PCR)
templates] were synthesized by Sigma Genosys (Israel),
and contained three copies of the decameric half-site of
Con1, Con2, Con3, Con4, Con5 or con6 (Table 2),
whereas the library DNA sequences (top PCR templates)
and the ﬂuorescein- and tetramethylrhodamine
(TAMRA)-labeled oligonucleotide primers (32) were
synthesized by the Keck Foundation Laboratory at Yale
University, and puriﬁed as previously described (32).
Binding stoichiometry measurements
The experiments were carried out by the continuous vari-
ation (Job plot) method (33). In this assay, the total molar
Table 1. Binding afﬁnity and cooperativity of p53DBD interaction with the p53 REs studied here
Name Sequence k1=k2=
dimer Kd
a
Ka2=k1k2k12=
tetramer Kd (M
2)
a
Dimer equiv
tetramer Kd
a,b
k12
a
Con1 CGGGCATGTCCGGGCATGTCCTG 314 (14)nM 1.0 (0.2) E-14 64 (4)nM 25 (2)
Con1 HS TGGTTGCGGGCATGTCCTGGGTA 305 (24)nM – – –
Con1 and 2-bp spacer CGGGCATGTCCgcGGGCATGTCCTG 442 (20)nM 3.9 (0.4) E-13 435 (32)nM 1.1 (0.2)
Con1 and 4-bp spacer CGGGCATGTCCtgctGGGCATGTCCTG 581 (46)nM 2.1 (0.2) E-12 1.02 (0.06)mM 0.34 (0.06)
Con2 CGGGCTAGTCCGGGCTAGTCCTG  25 (5)mM
c 1.0 (0.3) E-13 252 (19)nM  10000 (3000)
Con2 HS TGGTTGCGGGCTAGTCCTGGGTA 3.6 (0.4)mM– – –
Con2 and 2-bp spacer CGGGCTAGTCCgcGGGCTAGTCCTG 2.8 (0.3)mM 2 (1) E-11 3 (0.8)mM 0.9 (0.2)
Con2 and 4-bp spacer CGGGCTAGTCCtgctGGGCTAGTCCTG 9 (2)mM 2.8 (0.6) E-10 11 (2)mM 0.6 (0.1)
Con3 CGGGCAAGTCCGGGCAAGTCCTG  11 (1)mM
c 1.1 (0.1) E-13 227 (14)nM  2500 (500)
Con3 nicked dumbbell CGGCGGCGGGCA@AGTCCGGGCAAGTCCTG
d 600 (100)nM
e 1.1 (0.2) E-12 – 9.0 (0.6)
aThe values are average of four to eight independent experiments conducted with each sequence; the values in parenthesis are the standard error of
the mean.
bSince the half-sites are identical (k1=k2) one can take the square root of the expression for Ka2 and determine the ‘dimer equivalent tetramer Kd’,
cKd estimated by inserting zeros to account for the unobserved dimer bands (see text for details).
d@=nick in sequence. Double strands are held by two hairpin loops, i.e. a dumbbell. All other sequences contain a single hairpin loop at the 30 end.
eValue for dimer binding to the nicked half-site; the value for the other half site is that of the half site of Con3 (see text for details).
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1200nM, and the protein mole fraction was varied regu-
larly from 0 to 0.983 (0 to 590, 890 or 1180nM, respect-
ively). Other reaction conditions are as described below
for the binding afﬁnity measurements. In addition,
binding stoichiometry measurements were also carried
out by mixing of two different p53 constructs (p53DBD
and p53TD). This assay was carried out as described
below for the binding afﬁnity measurements, except that
protein concentration was an equimolar mixture of the
two proteins used in these experiments, and the EMSA
gels were 4% (37.5:1 acrylamide:bisacrylamide ratio).
Binding afﬁnity measurements
Radiolabeled and gel-puriﬁed hairpin duplexes (<0.1nM)
and increasing amounts of p53DBD were incubated on ice
for 2h in a buffer containing 50mM Tris–HCl (pH 7.5),
10mM MgCl2, 1mM ATP, 25U/ml BSA, 10% glycerol,
10mM DTT and 200mM KCl. Complexes were resolved
from free DNA by electrophoresis on native gels (6%,
37.5:1 acrylamide: bisacrylamide ratio). The gels were
run at 550 Vand 4 C in a running buffer containing 1  
TG [25mM Tris–HCl (pH 8.3), 190mM glycine], until the
bromophenol blue dye migrated 8cm.
Dried gels were quantiﬁed using a Fujii FLA 5000
phosphoimager. We have analyzed the system separately
for each bound band using TotalLab v2 (Nonlinear
Dynamics Ltd., UK). Boxes were deﬁned surrounding
each band on the gel, such that each box covered only
the main band, and did not include any gel-instability
smear extending forward on the gel. The sizes of the
boxes were deﬁned by the proﬁle option of TotalLab
and not by visual inspection of the gels. Overall back-
ground was subtracted from the entire gel in TotalLab
by deﬁning a box in the surrounding gel area that
produced a base line that passes at the bottom edge
of the bands peaks. In addition, we subtracted a local
background, only from the bound bands, such that the
region above the free DNA band, on the lane in which
no protein was added, was equal to exactly 0.00 unit of
photostimulated luminescence (PSL) from the
photostimulable phosphor image plate, to account for
possible trail of radioactivity left by the migration of
the free DNA ahead of the bound complexes (34). i,
the fraction of DNA molecules with i protein molecules
bound, was calculated from the equation: i=(PSL-bg)i/
i(PSL-bg)i where bg is the background, and the summa-
tion is over all the bands in a given lane.
Association binding constants were calculated using
nonlinear least-squares methods of parameter estimation
(SigmaPlot, Jandel Scientiﬁc, CA, USA). Since the stoichi-
ometry measurements have shown that the apparent
binding unit is a dimer of p53DBD (see ‘Results’
section), we used a regular two binding site model for all
target sites used in this study, except those that harbor
only one half-site (Con1HS and Con2HS), where we
used a regular one site model (35–37). For gel patterns
showing only the tetramer binding species, we added
zeros to account for the unobserved dimer bands. Thus,
the following equations were used:
0¼ 1=ð1+Ka1  ½ P +Ka2  ½ P 
2Þð 1Þ
1¼ Ka1 ½P =ð1+K a1 ½P +K a2 ½P 
2Þð 2Þ
2¼ Ka2 ½P 
2=ð1+Ka1 ½P +K a2 ½P 
2Þð 3Þ
Where P is the protein and the macroscopic association
binding constants are Ka1 and Ka2, for the dimeric and the
tetrameric species, respectively. Since in all target sites
(except nicked Con3) the two half-sites are identical, it is
possible to calculate intrinsic microscopic binding con-
stants and an explicit cooperativity constant (37) as
follows:
Ka1 ¼ k1+k2 ¼ 2ki ð4Þ
Ka2 ¼ k1k2k12 ¼ k2
i k12 ð5Þ
where k1, and k2 are the intrinsic microscopic binding con-
stants for each half-site and k12 is the cooperativity
constant (37). k12 measures the increase (or decrease) in
the binding afﬁnity of the second dimer relative to that of
the ﬁrst dimer due to the cooperativity of the binding
interaction. For targets with identical half-sites, and
assuming equipartition of binding free energies, an
apparent dimer-equivalent association constant can be
calculated by taking the square root of the Ka2 value.
The reported values (Table 1) are the dissociation
binding constants, which are the reciprocal of the
Table 2. Best-ﬁt parameters for p53 REs from analysis by cyclization kinetics
Name sequence Bend angle ( )
a,b Twist angle ( )
b Roll and tilt
ﬂuctuations ( )
b
Twist ﬂuctuations ( )
b Torsional force
constant 10
19erg·cm
con1 GGGCATGTCC 0.47 (0.09) 34.13 (0.11) 4.49 (0.10) 5.62 (0.09) 1.432
con2 GGGCTAGTCC 0.48 (0.07) 34.15 (0.10) 4.45 (0.08) 4.65 (0.07) 2.094
con3 GGGCAAGTCC 0.21 (0.08) 34.17 (0.10) 4.45 (0.10) 4.71 (0.07) 2.044
con4 (GGG) GGGCATGCCC 0.80 (0.09) 34.18 (0.11) 4.45 (0.10) 5.70 (0.09) 1.395
con5 (GGA) GGACATGTCC 0.85 (0.07) 34.22 (0.08) 4.51 (0.07) 5.21 (0.08) 1.671
con6 (AGG) AGGCATGCCT 0.45 (0.10) 34.16 (0.10) 4.43 (0.10) 5.47 (0.09) 1.514
B-DNA
c 0.61 (0.09) 34.22 (0.09) 4.50 (0.10) 5.06 (0.09) 1.771
All measurements were made at 21 C.
aBending is by roll and its center is located at the fourth step of all sequences, i.e. at the C-A or C-T step.
bNumbers in parenthesis are the simulation errors, calculated as described in ref. (40).
cFrom Zhang et al. (32).
Nucleic Acids Research,2011, Vol.39, No. 5 1921association binding constants. The values in parenthesis in
the tables, in ﬁgure legends and in the text are the standard
error of the mean (SEM). The error bars in the graphs are
standard deviation (SD).
Preparation of DNA constructs for cyclization
experiments
Constructs were synthesized using the PCR scheme de-
veloped by Zhang and Crothers (32). PCR was carried
out using the PCR-Ready High Yield clear kit (Syntezza
Bioscience Ltd, Israel), supplemented with 100ng of each
top and bottom DNA templates, and 0.5mM of each
primer in a ﬁnal volume of 50ml. The PCR had two
stages. In the ﬁrst stage, a double-stranded intermediate
was formed from the top and bottom templates by exten-
sion from the 10bp overlap between the templates (32).
This was done by subjecting the PCR tubes to 2min at
94 C, 2min at 30 C, then increase to 68 Cb y2  C incre-
ments/45 s and ﬁnally 72 C for 60s. The second stage
consisted of 31 cycles of 45s at 94 C, 59 C and 72 C,
which was terminated with 72 C for 15min. PCR
products were puriﬁed using Sephadex G-25
(Sigma-Alderich) columns, digested with 15 units of ClaI
enzyme in 60ml for 1–3h, and then puriﬁed on 10%
(37.5:1 acrylamide:bis) native gel (40cm long) in the
dark. DNA bands were cut out from the gel under ultra-
violet (UV) illumination after 15min staining with SYBR
gold solution (Molecular Probes). Gel pieces were
electroeluted and concentrated using millipore Centricon
(Ultracell YM-30) and Centrilutor Micro-Electroeluter
(Millipore). Residual SYBR gold was removed from the
stained DNA by EtOH precipitation.
Cyclization kinetics and simulation of cyclization data
Cyclization kinetics measurements were carried out as
described previously (32), using similar instrumentation.
DNA concentration was 0.5–2nM, which yielded initial
emission readings of 70–250 arbitrary units. Initially,
each DNA construct was measured in several ligase con-
centrations, to make sure that measurements are carried
out in the linear range of ligase concentrations (32). Final
ligase concentration used were 1kU/ml for constructs
156L14 (the in-phase construct for all test sequences)
and 156L16 of the phasing assay of all test sequences,
and constructs 154–160L14 of the total-length assay;
2kU/ml was used for all other constructs. The probability
of ring closure of DNA molecules, or the J-factor, is
deﬁned (38) as the ratio of the cyclization equilibrium
constant to the bimolecular equilibrium constant for
joining two molecules (J=Kc/Ka), and it has been
shown (39) to be equal (under certain conditions) to the
ratio of the corresponding rate constants (J=k1/k2). k2 is
the same for all constructs with the same cohesive ends,
and all measurements were done relative to a B-DNA test
sequence whose J-factor is known (32). From measure-
ments of the rate of cyclization of this construct
(k1
B-DNA) and its known J-factor, the J-factor of each
test sequence was determined by Jtest=JB-DNA*k1
test/
k1
B-DNA, for each speciﬁc ligase concentration.
Quantitative data on the conformational properties of
the tested DNA molecules were derived by computer
modeling of the experimental J-factors, based on a
model for the structural properties of the tested DNA
molecules. Simulation of the cyclization data was carried
out using the new theory developed by Zhang and
Crothers (40). The program we got was written for the
optimization of two structural parameters, and it was
extended by us to the simultaneous minimization of the
error between simulation and experimental values of four
structural parameters: bend angle, helical twist angle,
bend ﬂexibility and torsional ﬂexibility. Sixteen J-factors
were used for each simulation (ﬁve for the phasing assay
and 11 for the total-length assay).
Statistical analysis of validated p53 REs
The dispersion of averaged structural parameters from
their values in protein–DNA complexes (41), measured
by the standard deviation, was taken as a measure of
the ﬂexibilities of individual DNA base-pair steps. All cur-
rently available p53 REs (42) with decameric half-sites
that contain a CNNG motif at their center (241 half-sites)
were included in the analysis. For each sequence, we
calculated the mean and variance of the twist, slide and
roll dispersion along the entire half-site. We then grouped
these sequences by the identity of the NN step of the
central CNNG motif and calculated the mean and the
variance of these parameters for each group. We
calculated a two-sample t-statistic to assess the signiﬁ-
cance of the difference between groups, by calculating
the ratio of the difference between the mean values to
the standard error of the difference between the means,
separately for each structural parameter. The distributions
of the t statistic were approximated to a t-distribution by
using the exact method to calculate the degrees of freedom
from the data (43). Since the degrees of freedom, as
calculated by this method, depend on the variance of the
calculated parameter, they are different for each structural
parameter.
RESULTS AND DISCUSSION
Binding of p53DBD to p53 sites as a function of the
CWWG motif
The CWWG region is the most conserved region of p53
REs (44), even though the WW dinucleotide is
uncontacted in complex with p53DBD (12,13). To probe
the role of the non-contacted central dinucleotide in p53/
DNA interactions, we studied the effect of changing the
central step on p53DBD binding afﬁnity to these targets.
We started with the sequence GGGCATGTCC (Con1,
Table 1), because it is based on a decamer sequence that
was identiﬁed by in vitro selection experiments as a strong
p53-binding site (5), with high transactivation activity
in vivo (18). We then changed the middle dinucleotide
within each half-site to T–A (Con2, Table 1) or A–A
(Con3, Table 1). The results of EMSAs with these se-
quences are shown in Figure 1. Surprisingly, a major vari-
ability in this series was the stoichiometry of the binding
interaction, i.e. the oligomeric state of p53DBD in the
1922 Nucleic Acids Research, 2011,Vol.39, No. 5complexes formed with each target. Con1 showed two
distinct shifted bands, a dominant upper band and a
minor lower band, similar to those displayed by the se-
quences studied by Kitayner et al. (12), whereas Con2 and
Con3 show only the major upper band. Gel-mobility-shift
assays are unique in their ability to distinguish between
complexes that differ in their oligomeric composition
(37,45,46).
To quantify these gels with conﬁdence, and for each
species separately, we must ﬁrst determine the exact
binding stoichiometry of each complex in the gel. The stoi-
chiometry was determined using the continuous variation
(Job plot) assay (33). In this method, the total molar con-
centration of protein and DNA is held constant, whereas
their molar ratios are continuously varied, from only DNA
to almost only protein (Figure 2A). The ratio at which the
bound complex is maximal is the binding stoichiometry for
that complex. The reaction was carried out using the Con1
sequence with the total molar concentration ﬁxed at
600nM, which is thus signiﬁcantly above the dissociation
constant of the complex (Table 1). Approximating the ex-
perimental points by two lines of limiting slopes
(Figure 2B) produced a stoichiometry of 1:3.94 (0.06) for
the upper bound complex and 1:1.94 (0.08) for the lower
bound complex, which established that the upper bound
complex is a tetramer of p53DBD and the lower one is a
dimer of p53DBD bound to DNA. A proof for cooperative
binding is when the maximum in the Job plot (and hence
the resultant stoichiometry) is independent of the total
protein and DNA concentration (33). Hence, we repeated
the experiment at 900nM and at 1200nM total molar con-
centration (Supplementary Figure S1). The resulting stoi-
chiometry was 1:4.0 (0.2) and 1:1.96 (0.07) at 900nM, and
1:4.1 (0.2) and 1:2.1 (0.2) at 1200nM, for the upper and the
lower bound bands, respectively, thus establishing that
p53DBD binds cooperatively to its REs, whether the
binding is as a tetramer (upper bound band) or as a
dimeric species (lower bound band).
Another convenient method to easily check the binding
stoichiometry is to mix together two proteins constructs
differing only in their molecular weight (47). Therefore,
to further elucidate the nature of the different binding
species we ran an EMSA gel with the Con1 target, using
an equimolar mixture of two different p53 constructs:
p53DBD (amino acids 94–293) and p53TD (amino acids
1–290). Supplementary Figure S2A shows that p53TD
formed a complex with Con1 that migrates higher on the
gel than the complex containing p53DBD, and that only a
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Figure 1. Binding afﬁnity measurements by EMSA of p53 consensus REs as a function of the central CWWG motif. (A) Con1, with a central
CATG motif. (B) Con2, with CTAG. (C) Con3, with CAAG. DNA targets were imbedded in hairpin constructs (concentration <0.1nM). Upper
bands show protein bound DNA and lower bands show unbound DNA. The number below each gel is the concentration of p53DBD monomers
active for DNA binding. The gels are representative examples of four to eight independent experiments conducted with each sequence.
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Figure 2. Continuous variation analysis of p53DBD binding to Con1. (A) A representative EMSA gel of p53DBD binding to Con1 (of three
independent experiments). Total macromolecular concentration was ﬁxed at 600nM. The mole fraction of protein, shown below the gel, increased
across the gel. (B) Analysis by a Job plot of the data from (A). The lines are the least-square ﬁts to the rising and falling subsets of the data. Their
intersection yields a binding stoichiometry of 1:3.94 (0.06) for the upper bound complex and 1:1.94 (0.08) for the lower bound complex.
Nucleic Acids Research,2011, Vol.39, No. 5 1923single complex band is observed. Supplementary Figure
S2B shows that upon mixing the two proteins, the upper
band is split into three separate bands, of which the lower
one is the prominent one. This conﬁrmed that the upper-
most shifted band with Con1 and p53DBD is a tetramer,
and that this tetramer is composed of tightly held dimers.
Mixing of independent monomeric species would have
resulted in a split to ﬁve individual bands. It also conﬁrmed
thatthelowershiftedbandwithCon1andp53DBDisnota
tetramer. The N-terminal domain is known to have an in-
hibitory effect on the binding of the DBD to p53 targets
(48), which may be the reason why p53TD is not stably
bound as a dimer. This is also evident by the lower
binding afﬁnity of p53TD to Con1, as manifested by split
bands getting weaker as we go up in the gel pattern with the
combined proteins.
The gel pattern with the Con1 target, and speciﬁcally
the dimeric complex, is not a result of complex instability
during the electrophoretic run. This can be determined
from a time course of the reaction with the Con1 target,
where we incubated this target with p53DBD in the
regular conditions and loaded equal aliquots of the
reaction at 10-min intervals. Supplementary Figure S3
shows that there is no accumulation of the dimeric
species as a function of gel run time; on the contrary,
the dimeric species became depleted as the complex
migrated on the gel, due to gel instabilities. At the
second shortest run time (from the right-hand-side of the
gel), the dimeric species is 19 (1)% of the total of the two
bound bands, whereas at the longest run time it is 14 (2)%
of the total.
Changes in the CWWG motif leads to three orders-of-
magnitude differences in the degree of cooperative binding
We have quantiﬁed the binding afﬁnity in this study
separately for each bound band using a two binding site
model, shown for Con1, Con2 and Con3 in Figure 3A–C.
Such analysis assumes that the minimal binding unit for
p53DBD is apparently a dimer. It is known that in
solution p53DBD is monomeric (24). However, the
binding cooperativity for the monomer–dimer transition
is faster than can be observed using these methods. More
elaborate models, such as a four binding site model,
resulted in signiﬁcant worse ﬁt between the experimental
points and those of the model (data not shown). Since in
gels with the Con2 and Con3 targets no bands of dimeric
complexes were observed, we have included them in the
analysis as having zero occupancy. This led to a signiﬁcant
improvement in the ﬁt of the experimental data over that
of using a one-site model (tetramer only), or using a
two-site model without dimer occupancy included.
However, analysis by two equations that do not include
a term for Ka1 (dimer binding) resulted in the same
tetramer Kd.
The results of this analysis (Table 1) showed signiﬁcant
changes between the targets in both the binding afﬁnity
and especially in the binding cooperativity. Con1 sequence
showed the highest tetramer binding afﬁnity in this series
[64 (4)nM] and the lowest binding cooperativity [k12=25
(2), see ‘Material and Methods’ section for explanation on
analysis method]. Con2 showed the lowest tetramer
binding afﬁnity [252 (19)nM] and the highest binding
cooperativity (k12  10000), and Con3 showed values
between these two extremes [tetramer Kd=227 (14)nM,
and k12  2500]. There is a 4-fold difference in binding
afﬁnity between the sites, and a 400-fold difference in
the binding cooperativity. The binding afﬁnity of
p53DBD dimer to Con1 is 314 (14)nM. Cooperativity
constants above  1000 are not resolvable on EMSA gels
(37). They are indeed not observed in the gels of Con2 and
Con3 and hence we added them in the analysis with zero
occupancy in order to calculate the dimer binding afﬁnity
and cooperativity for these sites. The k12 values for Con2
and Con3 may therefore be only a rough estimate.
However, the difference in k12 values among these sites,
and between them and that of the Con1 target, is so large
that it allows us to conclude that the changes in binding
cooperativity between the sites are highly signiﬁcant.
In all analyzed sequences, we observed a slight system-
atic underestimation of the bound bands, and a slight sys-
tematic overestimation of the free DNA bands, which is
due to gel instabilities, at the 3–5 highest protein concen-
tration. When there is only one bound species in the gel
experiment (49,50), or when we analyze the bound species
together for overall afﬁnity (12), one can extend the bound
complexes bands downwards to include such instabilities.
However, here there is more than one bound species in the
complex with Con1, and hence we delimited the boxes
deﬁning the bound complexes tightly around each band.
This may also account for the difference in binding afﬁnity
of Con1 versus those studied by Kitayner et al. (12), where
we performed an overall analysis, with boxes extended to
the free DNA. Analysis for overall Kd of the Con1 target
led to a binding afﬁnity of 20 (2)nM, similar to that of the
GGG target of Kitayner et al. (12). However, only an
analysis for separate binding of each species can demon-
strate the vast differences in binding cooperativity between
binding sites observed here. EMSA methods, carried out
as described in this study, are known to yield robust and
precise quantitative results (45,46,51–53). Moreover,
EMSA has been shown to be useful also for accurate
quantitative determination of cooperativity in protein–
DNA interactions, when analyzed as described by
Senear and Brenowitz (37), even when the analyzed gels
are noisy.
Structural characterization of p53 sites as a function of
the non-contacted step
There are many known instances in which DNA is
deformed in protein–DNA complexes (54,55). Hence, the
different strength of binding and especially binding
cooperativity may be due to different deformabilities of
the studied targets (56), especially as the targets differ in a
region that is uncontacted by the protein in the protein/
DNA complex. To address this issue we have measured
the global structure and mechanical properties of
decamers of Con1, Con2 and Con3 half-sites using the
high-throughput DNA cyclization approach developed
by Zhang and Crothers (32). In this method, one
measures the J-factors of a series of DNA molecules, all
containing the same test sequence (see ‘Materials and
Methods’ section for details). The relationship between
1924 Nucleic Acids Research, 2011,Vol.39, No. 5the experimental data and DNA structure is obtained by
computer analysis, based on a model for the structural
properties of the tested sequences. Speciﬁcally, two
assays were performed – the phasing assay and the
total-length assay (32). In the ﬁrst assay, the total-length
is constant and the phasing between the test sequence and
sequences containing curved DNA (A-tracts) is varied.
Once the in-phase construct is determined, one varies the
total length of the constructs, preserving the relative orien-
tation of the two regions. The phasing assay is sensitive to
DNA curvature and bending ﬂexibility. The total-length
assay is sensitive to DNA helical repeat and to bending
and twist ﬂexibility. Overall, 16 DNA constructs are used
to determine four structural parameters for each sequence
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ﬂexibility).
Figure 4 shows the results of the phasing and
total-length assays for Con1 to Con3. From the ﬁnal
structural parameters (Table 2), it can be observed that
the signiﬁcant difference between these sequences is only
in their torsional ﬂexibility. The Con1 decamer is one of
the most torsionally ﬂexible sequences determined to date,
with 5.62 (0.09)  in twist ﬂuctuations, which result in a
torsional force constant of 1.432 10
 19 erg·cm.
Relative to the torsional ﬂexibility of generic B-DNA
measured by us [5.06 (0.06) , Table 2], both Con2 as
well as Con3 half-sites are more torsionally rigid [4.64
(0.07)  and 4.71 (0.07) , respectively]. To understand
whether Con1 is unique in being torsionally ﬂexible, we
determined by cyclization kinetics the structural properties
of three additional p53 consensus binding sites: GGG
(also called Con4), GGA (Con5) and AGG (Con6),
studied by Kitayner et al. (12). Supplementary Figure S4
shows the results of the phasing and total-length assay for
these sequences. The ﬁnal structural values (Table 2)
showed that all decamers with a CATG center are more
torsionally ﬂexible than sequences with a CAAG or
CTAG center. The torsional force constant varies with
the inverse square of the rms ﬂuctuation angle. Looking
at the values for the torsional force constant (Table 2) we
note that the Con4 target (1.395 10
 19 erg·cm) is  50%
more ﬂexible than either Con2 or Con3 (2.094 and
2.044 10
 19 erg·cm, respectively). The twist ﬂexibility
of the most torsionally rigid DNA molecule, measured
so far by cyclization kinetics, is 3.9 (0.3)  (56), which
amount to a force constant of 2.98 10
 19 erg·cm.
Thus, the whole range of sequence-dependent twist ﬂexi-
bility is  2-fold. Previously estimation of the range of
sequence-dependent torsional ﬂexibility ranged from
nonexistent (57) to around 2-fold (58). Thus, it seems
that the  2-fold range observed in DNA sequences
studied so far by cyclization kinetics is about the entire
range. Hence, the difference in the torsional force constant
between p53 binding sites studied here is signiﬁcant.
The high torsional ﬂexibility of all CATG decamers is
due to the combined ﬂexibilities of the C-A (T-G) steps
and not to that of the central A-T step. Using dimeric
steps taken from B-DNA crystal structures (59) or DNA
structure in protein–DNA complexes (41), Olson and
co-workers note that these steps are the most torsionally
ﬂexible of all dinucleotide combinations, as inferred from
the large dispersion values of these steps around their
averaged values.
CTAG containing sequences were proposed to be ex-
ceptionally ﬂexible (60), on account of the known ﬂexibil-
ity properties of T-A steps (61,62). T-A steps are indeed
anisotropically ﬂexible, but their structure is also very
context dependent, and thus sequences harboring T-A
steps are not well represented by nearest-neighbor
models (50). We showed here that within the sequence
context of the Con2 target, CTAG elements are torsion-
ally rigid relative to generic B-DNA sequences.
The twist ﬂexibility of the Con1–Con3 sequences and
the binding afﬁnity and binding cooperativity of these
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1926 Nucleic Acids Research, 2011,Vol.39, No. 5sequences show similar trends. The torsionally ﬂexible
Con1 target has the lowest binding cooperativity, the
intermediate dimer species is long-lived and stable
enough to show up as a separate entity on EMSA gels,
and the afﬁnity of the tetrameric complex is the highest of
the series. The relatively more rigid Con2 and Con3
targets show only tetramer bands of lower relative
afﬁnity. We suggest that it is the ﬂexible nature of the
Con1 target that reduces its cooperativity of interaction
and allows the formation of a long-lived and stable dimer
intermediate, on the way to the functional tetramer
species. The facile winding/unwinding motion of the
CATG motif allow the stabilization of inter-subunit inter-
actions within p53DBD, such that binding of only one
dimer to DNA is stable, the cooperativity is thus low
and the binding afﬁnity is relatively high, for both the
tetramer and the dimer (Table 1). This is not the case
for the more torsionally constrained CAAG (Con3) and
the CTAG (Con2) containing targets.
The signiﬁcance of torsional ﬂexibility in p53/DNA
interactions can be clearly visualized by calculating the
expected free energy difference of twisting p53 binding
sites by the twist angle observed in crystal structures. In
the GGG structure (Con4 in Table 2, the most torsionally
ﬂexible target), the difference between the A-T (24.1 ) and
the T-G (43.8 ) steps is 19.7  in twist angle (12). Similar
differences in the center CATG core have been observed in
other p53/DNA complexes with a CATG center (63,64).
The free energy difference for this amount of twist change
is 2.43 10
 13 erg or six times the thermal energy (kBT) at
21 C (the temperature at which the torsional force
constant was measured). For the Con2 target, the free
energy difference for the same twist angle change is
6.64 10
 13 erg, or nine times the thermal energy at
21 C. Thus, there is a 50% difference in the energetic
cost of twisting these two targets.
It was previously suggested (17,44) that DNA ﬂexibility
of p53 REs containing the CATG motif is an important
factor in the enhanced binding afﬁnity of such sites, but
these discussions do not differentiate between axial
(bending) ﬂexibility and torsional (twist) ﬂexibility. We
showed that there is ‘no axial ﬂexibility’ intrinsic to the
studied p53 targets, only ‘torsional ﬂexibility’. Nagaich
et al. (65) observed, by gel studies, that a sequence identi-
cal to the AGG target (12) is bent in solution in its free
state. We did not observe any static bending, or any
bendability of the sequences studies here and also not
when the AGG (Con6, Table 2) target was studied by
cyclization kinetics. Our study is the ﬁrst study to experi-
mentally determine the global structure and mechanical
properties of p53 REs by a sensitive and rigorous tech-
nique, carried out completely in solution, which does not
rely on external calibrators and is based on a complete
theoretical basis (66).
In the recent crystal structure determination of a 20-bp
duplex incorporating two contiguous decamers bound to
p53DBD, each DNA half-site is only slightly bent, and the
combined two half-sites are straight (67). Bending of the
magnitude displayed in this structure (as well as other
crystal structures of p53DBD/DNA complexes, refs.
12,13,63,64,68) is accessible to generic B-DNA molecules
that are not particularly axially ﬂexible (the free energy of
 20  or lower overall bends /10bp is below thermal
energy at 25 C, ref. 54). Thus, the energetic penalty cost
for formation of complexes with such bend magnitude is
negligible. This is in line with our observations of an
average axial ﬂexibility in the three target sites examined
here, regardless of their binding afﬁnity. On the other
hand, twist ﬂexibility of p53 DNA targets may be func-
tionally important. In the crystal structure determination
of two contiguous decamers bound to p53DBD (67),
the base pairing at the central A-T doublet shows the
Hoogsteen geometry. Further characterization, by the
Shakked group (67), of the mouse p53DBD tetramer co-
valently linked to a DNA duplex (64), shows that a large
fraction of the A-T central doublet is in the Hoogsteen
geometry also in this structure. The ability of CATG con-
taining DNA sequences, in complex with p53DBD, to
adopt both the Watson–Crick as well as the Hoogsteen
geometry is an indication of their large torsional ﬂexibil-
ity, because the ﬂip from Watson–Crick to Hoogsteen
geometry and vice versa should involve winding and un-
winding of the double helix.
Creating a torsional swivel in Con3 reduces its binding
cooperativity and stabilizes a bound dimer
To further corroborate our suggestion that torsional ﬂexi-
bility is responsible for the difference in binding afﬁnity
and cooperativity between sites differing in the
non-contacted step of the CWWG region, we introduced
a torsional swivel into the Con3 target (nicked Con3,
Table 1) by designing it as an intramolecular dumbbell,
containing two hairpin loops. The 50 and 30 ends meet at
the middle of the 50 half-site, and thus there is a nick in the
50 half-site sequence between the C-A and A-G steps,
which renders the nicked Con3 target highly torsionally
ﬂexible (as shown in other protein–DNA systems; refs.
31,32). The EMSA pattern for the nicked Con3 target
and p53DBD (Figure 5) showed two bound bands,
albeit less sharply deﬁned than those of Con1.
Quantitative analysis (Figure 3D and Table 1) was again
carried out using a two binding site model. The analysis
had now to be performed in terms of the macroscopic
constants, since the two half-sites are not identical
anymore. However, we can estimate the intrinsic binding
constant of the nicked half-site (k2) using the relationship
Ka1=k1+k2, assuming that we can take the intrinsic
binding constant of the intact half-site (k1) from measure-
ments of intact Con3. Such analysis showed that the
nicked Con3 half-site [600 (100)nM, Table 1] have
 20-fold higher afﬁnity compared to the estimated Kd of
the dimer from the intact Con3 half-site. The cooperativity
constant can be estimated from the expression of Ka2 and
the known values for k1 and k2, and it value [9.0 (0.6)]
showed that the binding cooperativity to the nicked Con3
binding site is lower than that to the ﬂexible Con1 site.
DNA with a nick in the backbone (and with a 30-end
phosphate) was shown by Zhang and Crothers (32) to
have twist ﬂuctuations of 6.8 (1.2) , signiﬁcantly more
ﬂexible than Con1. Such high twist ﬂexibility allows the
monomers within each dimer to re-adjust their relative
Nucleic Acids Research,2011, Vol.39, No. 5 1927conformation at low energetic cost, and thus they form
stable and long-lived dimers, leading to low cooperativity
of interaction of the nicked Con3 with p53DBD. This
extends the trend observed with the Con1–Con3 series of
inverse relationship between twist ﬂexibility and
cooperativity–high twist ﬂexibility and low cooperativity
of interaction and vice versa. However, here the trend does
not include high afﬁnity of tetramers of p53DBD binding
to targets with high twist ﬂexibility. The binding afﬁnity of
the tetramer complex to nicked Con3 was signiﬁcantly
reduced (Table 1) relative to that of intact Con3,
probably due to lose of contacts to the DNA backbone
(12).
Binding of p53DBD to p53 targets with spacers between
half-sites
In the p53 consensus the two half-sites can be separated by
up to 13bp (4). More recent studies show, however, that
spacer sequences of more than a few nucleotides decrease
p53 responsiveness from these sites (11,20), and attenuates
p53 binding afﬁnity (44). We asked whether the differen-
tial effects of the non-contacted WW step shown above
would differently affect binding, when spacer sequences
are introduced into the Con1 versus the Con2 targets.
For the Con1 target with spacers between half-sites the
observed gel pattern (Figure 6A and B) was again of
two bound complexes, dimers and tetramers of
p53DBD, as previously observed by Kitayner et al. (12).
Comparing the binding pattern of Con1, Con1 and 2-bp
spacer, and Con1 and 4-bp spacer side-by-side on the
same gel (Supplementary Figure S5) showed that the
dimeric species migrated to the same distance on the gel
in all complexes with these targets. The tetrameric species
migrated to decreasing distances on the gel as a function
of the spacer length. This may be due to differences in
twisting of the DNA in the complexes. Quantitative
analysis of the binding afﬁnity of p53DBD to these sites
(Figure 3E and F and Table 1) showed that the dimeric
species bound with slightly reduced Kd to that observed in
the Con1 target [442 (20)nM and 581 (46)nM for the in-
sertion of 2- and 4-bp spacer respectively, Table 1].
Signiﬁcant reduction in binding afﬁnity relative to that
in Con1 was observed for the tetrameric species [435
(32)nM and 1.02 (0.06)mM for the sites with 2- and
4-bp spacers respectively, Table 1], corresponding to
reduced protein–protein interactions in the inter-dimer
interface, in comparison to protein–protein contacts in
the complex with contiguous DNA site (67). The
cooperativity of interaction is reduced from that
observed for Con1 to 1.1(1) with 2-bp spacer and 0.34
(0.06) with 4-bp spacer (Table 1). Altogether, the
cooperativity differences between p53 target sites
spanned ﬁve orders of magnitude, as a function of
binding site sequence and spacers. No signiﬁcant
binding, of either binding stoichiometry, can be observed
to the Con2 targets with spacer sequences (Figure 6C and
D). Analysis (Figure 3G and H and Table 1) showed that
the binding afﬁnity for both species is in the micromolar
range.
Binding of p53DBD to p53 half-sites
Binding afﬁnity of the dimeric species can be affected by
gel instabilities from the tetrameric band above it. To
avoid this, and to explore whether p53DBD binds
half-sites as dimers or tetramers, we constructed target
sites comprising only one speciﬁc decamer, embedded in
the center of a hairpin of the same length as the other sites,
such that there are no surrounding nonspeciﬁc decameric
half-sites. EMSA pattern with the Con1 half-site (Con1
HS, Figure 7A) had one bound species, identiﬁed by a
Job plot analysis (Supplementary Figure S6) as a dimer.
Analysis of binding afﬁnity by a one-site model (Figure 3I)
yielded a Kd of 305 (24)nM, which is similar to that of the
dimeric complexes with Con1. Again, no appreciable
binding was observed to Con2 half-site (Con2 HS,
Figure 7B). Binding afﬁnity to Con2 HS is again in the
micromolar range (Figure 3J and Table 1).
Statistical analysis of validated p53 half-sites grouped by
the central CNNG motif
We have measured in this study the ﬂexibility of six deﬁned
p53 consensus targets, with variations in the CWWG motif
at their center, and noted a signiﬁcant difference in the
observed torsional ﬂexibility of the A-T containing
targets from that observed in the T-A or the A-A targets.
Other central dinucleotide steps are found in natural p53
REs (within CNNG motifs), and they are imbedded within
different ﬂanking contexts, which have a consensus of
RRR (and YYY), but from which most p53 REs deviate,
in at least one position (42,44). We wanted to assess the
centrality of the structural properties of the core CNNG
motif in determining the overall intrinsic ﬂexibility of p53
RE half-sites (that is along the entire decameric half-site).
Thus, we asked whether we can group all available
p53 RE half-sites, based on the identity of the central
tetranucleotide, and whether such clustering will result in
groups thataresigniﬁcantly distinctfrom each other, based
on their structural parameters. In order to carry out such
analysis,weassumedthatwecanrepresentDNAsequences
p53DBD [nM]
0
1
2
5
1
0
2
0
4
0
6
0
8
0
1
2
0
3
0
0
6
0
0
1
2
0
0
3
0
0
0
6
0
0
0
Figure 5. Binding afﬁnity measurements by EMSA of p53DBD
binding to the Con3 target with a nick in the center of the 50-half-
site (as shown in Table 1). This DNA target was synthesized as an
intramolecular dumbbell construct with two hairpin loops. For other
details, see Figure 1.
1928 Nucleic Acids Research, 2011,Vol.39, No. 5based on nearest-neighbor interactions only, so that we can
carry out calculations on the structural deformability of
DNA sequences from knowledge of the deformability of
all DNA doublets. Olson et al. (41) have studied the
sequence-dependent deformability of DNA doublets,
based on their conformation in protein–DNA complexes.
This data set was the only available dinucleotide properties
dataset that when we used it to calculate the torsional ﬂexi-
bility of the six p53 binding sites for which we have cycliza-
tion kinetics data, we got a good-enough correspondence
between the dispersion values of dinucleotide steps around
their mean value and our experimental measurements
( =0.971, P=0.04) to suggest that these dispersion
values can be used as a measure for the intrinsic
sequence-dependent ﬂexibility of DNA base-pair steps.
DNA structural parameters that show the largest vari-
ability, as a function of base-pair step identity, are twist,
roll and slide (41,69,70). We therefore calculated the mean
twist, roll and slide ﬂexibility for each known p53 RE
half-site (42), using the dispersion values from Olson
et al. (41), and then calculated the mean of the mean for
sequences grouped by the central tetranucleotide. We
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Figure 6. Binding afﬁnity measurements by EMSA of p53DBD binding to REs with spacers between half-sites. (A) Con1 with 2-bp spacer. (B) Con1
with 4-bp spacer. (C) Con2 with 2-bp spacer. (D) con2 with 4-bp spacer. For details, see Figure 1.
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Figure 7. Binding afﬁnity measurements by EMSA of p53DBD binding to half-site REs. (A) Con1HS. (B) Con2HS. For details, see Figure 1.
The band below the bound band in (B) (which is a complex of p53DBD dimer to con2HS) may be a p53DBD monomer bound to con2HS.
Nucleic Acids Research,2011, Vol.39, No. 5 1929included in this analysis only p53 REs that have decameric
half-sites and that contain a central CNNG core. The
results (Supplementary Table S1) showed that sequences
with a CATG center have the highest torsional ﬂexibility,
slide ﬂexibility and roll ﬂexibility, whereas sequences with
a CTAG center have the lowest ﬂexibility in these param-
eters, relative to CATG or CAAG, even though now the
sequences have various sequence motifs ﬂanking a speciﬁc
central tetranucleotide core. We carried out statistical tests
to assess the signiﬁcance of these results (Supplementary
Table S2), which showed that the differences between
CATG and either CAAG or CTAG groups are highly
signiﬁcant (P-values are 4.0E-10 and lower), in either ro-
tational twist ﬂexibility or translational slide ﬂexibility.
Overall, the differences between the groups with respect
to changes in the roll parameter are of lower signiﬁcance.
Many other signiﬁcant differences can be noted, especially
between CATG and other groups, or CTAG and other
groups, because these two groups are the two extreme
ends of values of ﬂexibility parameters. Even if we
multiply the P-values by 45, to account for multiple com-
parisons (15 comparisons and by three parameters, ref. 43)
many signiﬁcant differences remain, especially between
CATG and other groups, and CTAG and other groups.
Changes in twist, slide and roll are not independent of
each other (41,70,71); however, as the differences
between the groups are so signiﬁcant, there is no need to
carry out a multivariate analysis to test for signiﬁcant
clustering patterns using twist, slide and roll dispersion
together.
Function from p53 half-sites follows their binding and
structural characteristics
It is now established that p53 can function also from p53
half-sites. Menendez et al. (72) showed that a p53 consen-
sus half-site generated by a C to T SNP in the ﬂt-1
promoter can support  25% of the transactivation level
of the p21-50 RE. Combined with a nearby estrogen
receptor RE, and upon treatment with estradiol, the trans-
activation level increases 4-fold, to that from the potent
p21-50 RE (73). That p53 can transactivate from p53
half-sites was also established from half-site RE found in
the RAP80 promoter (74), where only slight reduction is
observed relative to the full RE (the full RE contains a
4-bp spacer). These results expand the universe of poten-
tial p53 RE and with it the ability to ﬁne tune p53
regulated genes. A clear trend can be established
between the identity of the CWWG motif and transacti-
vation from p53 half-sites (20). A sequence identical to
Con1HS (with a CATG center) showed the highest trans-
activation level of all CWWG half-site variants, followed
by Con3HS (with CAAG, 5-fold reduction in transcrip-
tion level), whereas Con2HS (with a CTAG center) hardly
showed any transactivation ability (20). This follows our
binding afﬁnity measurements as well as the torsional
ﬂexibility of the CWWG sites studied here. Based on
our results we interpret these observations as resulting
from the inability of p53 to bind CTAG containing
half-sites, which is due to the relative torsional rigidity
of such sequences.
Cooperative binding by p53DBD—implications for
functional binding by full-length p53 and by p53 isoforms
Here, we studied the binding characteristics of p53DBD to
several consensus target sites. This is not the functional
form of p53 in vivo. However, it is now known that the p53
gene encodes at least ten different p53 protein isoforms as
a result of alternative splicing (75–78). Some variants lack
part of the N-terminal region (the TA domain), whereas
other variants lack the parts of the tetramerization
domain and/or the extreme C-terminal regulatory
domain (78). It has been suggested that p53 isoforms
may modulate wt p53 (the canonical form of p53)
activity by modulating DNA binding, by the formation
of hetero-oligomers, and/or by sequestering p53 in the
cytoplasm. Alternatively, p53 isoforms may have autono-
mous specialized functions (78). This may be isoform de-
pendent and/or cell-type speciﬁc (77,78). Furthermore,
p53 isoforms arise most commonly because of splice-site
mutations, which may lead to exon skipping, or the
creation of new splice sites (79,80). Although at this
stage the observations on p53 isoforms, in normal and
cancerous cells, are sometimes conﬂicting (discussed in
refs. 78 and 81–83), advancing our detailed understanding
of the ability of various p53 truncation constructs to bind
various p53 target sites is important for cancer diagnosis
and treatment.
We showed in this study that there are ﬁve order of
magnitude changes of cooperative binding of p53DBD
to speciﬁc targets as a function of changes in consensus
sequences. Whenever the cooperativity constant is above
 1000 no intermediate species are observed (37). Indeed,
for complexes of p53DBD with the Con2 and Con3
targets no dimer bands are observed. Nonetheless, there
is a signiﬁcant change in cooperative interaction between
these two sites. The binding of full-length p53 to DNA
was suggested to be as cooperative (or more) than the
binding of p53DBD to DNA (24). We suggest that
binding of full-length p53 to DNA may show similar
cooperativity changes as a function of DNA base
sequence, even though it may bind to it REs only as a
tetramer, because of higher cooperativity of interaction.
Further studies will provide information on the effect of
domains outside the DBD on sequence-dependent binding
cooperativity of p53 to its REs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENT
We thank Zippi Shakked for puriﬁed p53DBD and
p53TD, for critical reading of the manuscript, and for
many helpful discussions. We thank Yongli Zhang and
Don Crothers for initiating us into the cyclization
kinetics method. We thank Mike Fried for bringing into
our attention the continuous variation method for stoichi-
ometry determination. We thank Mike Resnick for critical
reading of an initial version of this manuscript. We thank
Lev Greenberg for help with the statistical analysis.
1930 Nucleic Acids Research, 2011,Vol.39, No. 5FUNDING
The Israel Science Foundation (grant No.104405); Israel
Cancer Research Fund (grant No. 800005); German-Israel
Foundation (grant No. 890007). Funding for open access
charge: Israel Cancer Research Fund.
Conﬂict of interest statement. None declared.
REFERENCES
1. Vogelstein,B., Lane,D. and Levine,A.J. (2000) Surﬁng the p53
network. Nature, 408, 307–310.
2. Vousden,K.H. and Lu,X. (2002) Live or let die: the cell’s
response to p53. Nat. Rev. Cancer, 2, 594–604.
3. Oren,M. (2003) Decision making by p53: life, death and cancer.
Cell Death Differ., 10, 431–442.
4. El-Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and
Vogelstein,B. (1992) Deﬁnition of a consensus binding site for
p53. Nature Gen., 1, 45–49.
5. Funk,W.D., Pak,D.T., Karas,R.H., Wright,W.E. and Shay,J.W.
(1992) A transcriptionally active DNA-binding site for human
p53 protein complexes. Mol. Cell Biol., 12, 2866–2871.
6. Vousden,K.H. and Lane,D.P. (2007) p53 in health and disease.
Nat. Rev. Mol. Cell. Biol., 8, 275–283.
7. Vousden,K.H. and Prives,C. (2009) Blinded by the light: the
growing complexity of p53. Cell, 137, 413–431.
8. Laptenko,O. and Prives,C. (2006) Transcriptional regulation by
p53: one protein, many possibilities. Cell Death Differ., 13,
951–961.
9. Hupp,T.R. (1999) Regulation of p53 protein function through
alterations in protein-folding pathways. Cell. Mol. Life Sci., 55,
88–95.
10. Weisz,L., Oren,M. and Rotter,V. (2007) Transcription regulation
by mutant p53. Oncogene, 26, 2202–2211.
11. Tokino,T., Thiagalingam,S., el-Deiry,W.S., Waldman,T.,
Kinzler,K.W. and Vogelstein,B. (1994) p53 tagged sites from
human genomic DNA. Hum. Mol. Genet., 3, 1537–1542.
12. Kitayner,M., Rozenberg,H., Kessler,N., Rabinovich,D.,
Shaulov,L., Haran,T.E. and Shakked,Z. (2006) Structural basis of
DNA recognition by p53 tetramers. Mol. Cell, 22, 741–753.
13. Cho,Y., Gorina,S., Jeffrey,P.D. and Pavletich,N.P. (1994) Crystal
structure of a p53 tumor suppressor–DNA complex:
understanding tumorigenic mutations. Science, 265, 346–355.
14. Qian,H., Wang,T., Naumovski,L., Lopez,C.D. and
Brachmann,R.K. (2002) Groups of p53 target genes involved in
speciﬁc p53 downstream effects cluster into different classes of
DNA binding sites. Oncogene, 21, 7901–7911.
15. Hoh,J., Jin,S., Parrado,T., Edington,J., Levine,A.J. and Ott,J.
(2002) The p53MH algorithm and its application in detecting
p53-responsive genes. Proc. Natl Acad. Sci. USA, 99, 8467–8472.
16. Wei,C.L., Wu,Q., Vega,V.B., Chiu,K.P., Ng,P., Zhang,T.,
Shahab,A., Yong,H.C., Fu,Y., Weng,Z. et al. (2006) A global
map of p53 transcription-factor binding sites in the human
genome. Cell, 124, 207–219.
17. Weinberg,R.L., Veprintsev,D.B., Bycroft,M. and Fersht,A.R.
(2005) Comparative binding of p53 to its promoter and DNA
recognition elements. J. Mol. Biol., 348, 589–596.
18. Inga,A., Storici,F., Darden,T.A. and Resnick,M.A. (2002)
Differential transactivation by the p53 transcription factor is
highly dependent on p53 level and promoter target sequence.
Mol. Cell. Biol., 22, 8612–8625.
19. Wang,B., Xiao,Z. and Ren,E.C. (2009) Redeﬁning the p53
response element. Proc. Natl Acad. Sci. USA, 106, 14373–14378.
20. Jordan,J.J., Menendez,D., Inga,A., Nourredine,M., Bell,D. and
Resnick,M.A. (2008) Noncanonical DNA motifs as
transactivation targets by wild type and mutant p53.
PLoS Genet., 4, e1000104.
21. Wang,Y., Schwedes,J.F., Parks,D., Mann,K. and Tegtmeyer,P.
(1995) Interaction of p53 with its consensus DNA-binding site.
Mol. Cell. Biol., 15, 2157–2165.
22. Balagurumoorthy,P., Sakamoto,H., Lewis,M.S., Zambrano,N.,
Clore,G.M., Gronenborn,A.M., Appella,E. and Harrington,R.E.
(1995) Four p53 DNA-binding domain peptides bind natural
p53-response elements and bend the DNA. Proc. Natl Acad. Sci.
USA, 92, 8591–8595.
23. McLure,K.G. and Lee,P.W.K. (1998) How p53 binds DNA as a
tetramer. EMBO J., 17, 3342–3350.
24. Weinberg,R.L., Veprintsev,D.B. and Fersht,A.R. (2004)
Cooperative binding of tetrameric p53 to DNA. J. Mol. Biol.,
341, 1145–1159.
25. Dehner,A., Klein,C., Hansen,S., Muller,L., Buchner,J.,
Schwaiger,M. and Kessler,H. (2005) Cooperative binding of p53
to DNA: regulation by protein–protein interactions through a
double salt bridge. Angew. Chem. Int. Ed. Engl., 44, 5247–5251.
26. Klein,C., Planker,E., Diercks,T., Kessler,H., Kunkele,K.P.,
Lang,K., Hansen,S. and Schwaiger,M. (2001) NMR spectroscopy
reveals the solution dimerization interface of p53 core domains
bound to their consensus DNA. J. Biol. Chem., 276,
49020–49027.
27. Rippin,T.M., Freund,S.M., Veprintsev,D.B. and Fersht,A.R.
(2002) Recognition of DNA by p53 core domain and location of
intermolecular contacts of cooperative binding. J. Mol. Biol., 319,
351–358.
28. Veprintsev,D.B., Freund,S.M., Andreeva,A., Rutledge,S.E.,
Tidow,H., Canadillas,J.M., Blair,C.M. and Fersht,A.R. (2006)
Core domain interactions in full-length p53 in solution.
Proc. Natl Acad. Sci. USA, 103, 2115–2119.
29. Gasteiger,E., Hoogland,C., Gattiker,A., Duvaud,S., Wilkins,M.R.,
Appel,R.D. and Bairoch,A. (2005) In Walker,J.M. (ed.), The
Proteomics Protocols Handbook. Humana Press Inc., Totowa, NJ,
pp. 571–607.
30. Bareket-Samish,A., Cohen,I. and Haran,T.E. (2000) Signals for
TBP/TATA box recognition. J. Mol. Biol., 299, 965–977.
31. Hines,C.S., Meghoo,C., Shetty,S., Biburger,M., Brenowitz,M. and
Hegde,R.S. (1998) DNA structure and ﬂexibility in the
sequence-speciﬁc binding of papillomavirus E2 proteins.
J. Mol. Biol., 276, 809–818.
32. Zhang,Y. and Crothers,D.M. (2003) High-throughput approach
for detection of DNA bending and ﬂexibility based on
cyclization. Proc. Natl Acad. Sci. USA, 100, 3161–3166.
33. Huang,C.Y. (1985) Determination of binding stoichiometry by the
continuous variation method: the Job plot. Methods Enzymol., 87,
509–525.
34. Bareket-Samish,A., Cohen,I. and Haran,T.E. (1997) Repressor
assembly at trp binding sites is dependent on the identity of the
intervening dinucleotide between the binding half sites. J. Mol.
Biol., 267, 103117.
35. Eisenberg,D.S. and Crothers,D.M. (1979) Physical Chemistry with
Applications in the Life Sciences, Benjamin/Cummings Pub.
Comp., Menlo Park, CA.
36. Fried,M. and Crothers,D.M. (1981) Equilibria and kinetics of lac
repressor–operator interactions by polyacrylamide gel
electrophoresis. Nucleic Acids Res., 9, 6505–6525.
37. Senear,D.F. and Brenowitz,M. (1991) Determination of binding
constants for cooperative site-speciﬁc protein–DNA interactions
using the gel mobility-shift assay. J. Biol. Chem., 266,
13661–13671.
38. Jacobson,H. and Stockmayer,W.H. (1950) Intramolecular reaction
in polycondensations. 1. The theory of linear systems. J. Chem.
Phys., 18, 1600–1606.
39. Shore,D., Langowski,J. and Baldwin,R.L. (1981) DNA
ﬂexibility studied by covalent closure of short fragments into
circles. Proc. Natl Acad. Sci. USA, 78, 4833–4837.
40. Zhang,Y. and Crothers,D.M. (2003) Statistical mechanics of
sequence-dependent circular DNA and its application for DNA
cyclization. Biophys. J., 84, 136–153.
41. Olson,W.K., Gorin,A.A., Lu,X.J., Hock,L.M. and Zhurkin,V.B.
(1998) DNA sequence-dependent deformability deduced from
protein–DNA crystal complexes. Proc. Natl Acad. Sci. USA, 95,
11163–11168.
42. Menendez,D., Inga,A. and Resnick,M.A. (2009) The expanding
universe of p53 targets. Nat. Rev. Cancer., 9, 724–737.
43. Moore,D.S. and McCabe,G.P. (1989) Introduction to the Practice
of Statistics. W. H. Freeman and Company, New York.
Nucleic Acids Research,2011, Vol.39, No. 5 193144. Riley,T., Sontag,E., Chen,P. and Levine,A. (2008) Transcriptional
control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol.,
9, 402–412.
45. Fried,M.G. and Daugherty,M.A. (1998) Electrophoretic analysis of
multiple protein–DNA interactions. Electrophoresis, 19, 1247–1253.
46. Adams,C.A. and Fried,M.G. (2007) In. In Schuck,P. (ed.),
Protein Interactions: Biophysical Approaches for the Study of
Complex Reversible Systems. Academic Press, New York,
pp. 417–446.
47. Hope,I.A. and Struhl,K. (1987) GCN4, a eukaryotic
transcriptional activator protein, binds as a dimer to target DNA.
EMBO J., 6, 2781–2784.
48. Cain,C., Miller,S., Ahn,J. and Prives,C. (2000) The N terminus of
p53 regulates its dissociation from DNA. J. Biol. Chem., 275,
39944–39953.
49. Faiger,H., Ivanchenko,M., Cohen,I. and Haran,T.E. (2006) TBP
ﬂanking sequences: asymmetry of binding, long-range effects and
consensus sequences. Nucleic Acids Res., 34, 104–119.
50. Faiger,H., Ivanchenko,M. and Haran,T.E. (2007)
Nearest-neighbor non-additivity versus long-range non-additivity
in TATA-box structure and its implications for TBP-binding
mechanism. Nucleic Acids Res., 35, 4409–4419.
51. Carey,J. (1988) Gel retardation at low pH resolves trp repressor–
DNA complexes for quantitative study. Proc. Natl Acad. Sci.
USA, 85, 975–979.
52. Fried,M.G. (1989) Measurement of protein–DNA interaction
parameters by electrophoresis mobility shift assay. Electrophoresis,
10, 366–376.
53. Cann,J.R. (1989) Phenomenological theory of gel electrophoresis
of protein–nucleic acid complexes. J. Biol. Chem., 264,
17032–17040.
54. Bloomﬁeld,V.A., Crothers,D.M. and Tinoco,I.J. (2000) Nucleic
Acids: Structures, Properties, and Functions. University Science
Books, Sausalito.
55. Dickerson,R.E. (1998) DNA bending: the prevalence of kinkiness
and the virtues of normality. Nucleic Acids Res., 26, 1906–1926.
56. Zhang,Y., Xi,Z., Hegde,R.S., Shakked,Z. and Crothers,D.M.
(2004) Predicting indirect readout effects in protein–DNA
interactions. Proc. Natl Acad. Sci. USA, 101, 8337–8341.
57. Fujimoto,B.S. and Schurr,J.M. (1990) Dependence of the
torsional rigidity of DNA on base composition. Nature, 344,
175–177.
58. Chen,H.H., Rau,D.C. and Charney,E. (1985) The ﬂexibility of
alternating dA-dT sequences. J. Biomol. Struct. Dyn., 2, 709–719.
59. Gorin,A.A., Zhurkin,V.B. and Olson,W.K. (1995) B-DNA
twisting correlates with base-pair morphology. J. Mol. Biol., 247,
34–48.
60. Dlakic,M. and Harrington,R.E. (1995) Bending and torsional
ﬂexibility of G/C-rich sequences as determined by cyclization
assays. J. Biol. Chem., 270, 29945–29952.
61. Travers,A.A. and Klug,A. (1990) In. In Cozzarelli,N.R. and
Wang,J.C. (eds), DNA Topology and Its Biological Effects. Cold
Spring Harbor Press, Cold Spring Harbor, pp. 57–106.
62. Widom,J. (2001) Role of DNA sequence in nucleosome stability
and dynamics. Q. Rev. Biophys., 34, 269–324.
63. Ho,W.C., Fitzgerald,M.X. and Marmorstein,R. (2006) Structure
of the p53 core domain dimer bound to DNA. J. Biol. Chem.,
281, 20494–20502.
64. Malecka,K.A., Ho,W.C. and Marmorstein,R. (2009) Crystal
structure of a p53 core tetramer bound to DNA. Oncogene, 28,
325–333.
65. Nagaich,A., Zhurkin,V.B., Durrel,S.R., Jernigan,R.L., Appella,E.
and Harrington,R.E. (1999) p53-induced DNA bending and
twisting:p53 tetramer binds on the outer side of a DNA loop and
increases DNA twisting. Proc. Natl Acad. Sci. USA, 96,
1875–1880.
66. Crothers,D.M., Drak,J., Kahn,J.D. and Levene,S.D. (1992) DNA
bending, ﬂexibility, and helical repeat by cyclization kinetics.
Methods Enzymol., 212, 3–29.
67. Kitayner,M., Rozenberg,H., Rohs,R., Suad,O., Rabinovich,D.,
Honig,B. and Shakked,Z. (2010) Diversity in DNA recognition
by p53 revealed by crystal structures with Hoogsteen base pairs.
Nat. Struct. Mol. Biol., 17, 423–429.
68. Chen,Y., Dey,R. and Chen,L. (2010) Crystal structure of the p53
core domain bound to a full consensus site as a self-assembled
tetramer. Structure, 18, 246–256.
69. Shakked,Z. and Rabinovich,D. (1986) The effect of the base
sequence on the ﬁne structure of the DNA double helix.
Prog. Biophys. Mol. Biol., 47, 159–195.
70. El Hassan,M. and Calladine,C.R. (1997) Conformational
characteristics of DNA: empirical classiﬁcations and a
hypothesis for the conformational behaviour of dinucleotide
steps. Phil. Trans. Roy. Soc. Lond., A 355, 43–100.
71. Dickerson,R.E. (1999) In. In Neidle,S. (ed.), Oxford Handbook of
Nucleic Acid Structure. Oxford University Press, New York,
pp. 145–197.
72. Menendez,D., Krysiak,O., Inga,A., Krysiak,B., Resnick,M.A. and
Schonfelder,G. (2006) A SNP in the ﬂt-1 promoter integrates
the VEGF system into the p53 transcriptional network.
Proc. Natl Acad. Sci. USA, 103, 1406–1411.
73. Menendez,D., Inga,A., Snipe,J., Krysiak,O., Schonfelder,G. and
Resnick,M.A. (2007) A single-nucleotide polymorphism in a
half-binding site creates p53 and estrogen receptor control of
vascular endothelial growth factor receptor 1. Mol. Cell Biol., 27,
2590–2600.
74. Yan,J., Menendez,D., Yang,X.P., Resnick,M.A. and Jetten,A.M.
(2009) A regulatory loop composed of RAP80-HDM2-p53
provides RAP80-enhanced p53 degradation by HDM2 in response
to DNA damage. J. Biol. Chem., 284, 19280–19289.
75. Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G.,
Diot,A., Xirodimas,D.P., Saville,M.K. and Lane,D.P. (2005) p53
isoforms can regulate p53 transcriptional activity. Genes Dev., 19,
2122–2137.
76. Rohaly,G., Chemnitz,J., Dehde,S., Nunez,A.M., Heukeshoven,J.,
Deppert,W. and Dornreiter,I. (2005) A novel human p53 isoform
is an essential element of the ATR-intra-S phase checkpoint. Cell,
122, 21–32.
77. Khoury,M.P. and Bourdon,J.C. (2010) The isoforms of the p53
protein. Cold Spring Harb. Perspect. Biol., 2, a000927.
78. Marcel,V. and Hainaut,P. (2009) p53 isoforms - a conspiracy to
kidnap p53 tumor suppressor activity? Cell. Mol. Life Sci., 66,
391–406.
79. Holmila,R., Fouquet,C., Cadranel,J., Zalcman,G. and Soussi,T.
(2003) Splice mutations in the p53 gene: case report and review
of the literature. Hum. Mutat., 21, 101–102.
80. Hofstetter,G., Berger,A., Fiegl,H., Slade,N., Zoric,A., Holzer,B.,
Schuster,E., Mobus,V.J., Reimer,D., Daxenbichler,G. et al. (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant
p53delta is an independent prognostic marker in ovarian cancer.
Oncogene, 29, 1997–2004.
81. Deppert,W. (2009) Alternatively spliced p53 isoforms: alternative
views or alternative functions? Cell Cycle, 8, 1645.
82. Bourdon,J.C. (2007) p53 and its isoforms in cancer.
Br. J. Cancer, 97, 277–282.
83. Machado-Silva,A., Perrier,S. and Bourdon,J.C. (2010) p53 family
members in cancer diagnosis and treatment. Semin. Cancer Biol.,
20, 57–62.
1932 Nucleic Acids Research, 2011,Vol.39, No. 5